Aprea Therapeutics
$22.469876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$22.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.19 (-0.84%) As of 1:55 PM EDT today
Why Robinhood?
You can buy or sell APRE and other stocks, options, ETFs, and crypto commission-free!
About APRE
Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Read More The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA. The listed name for APRE is Aprea Therapeutics, Inc. Common stock.
Employees
—
Headquarters
Boston, Massachusetts
Founded
2002
Market Cap
476.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
126.48K
High Today
$23.24
Low Today
$21.93
Open Price
$22.66
Volume
56.65K
52 Week High
$53.11
52 Week Low
$15.10
Collections
APRE Earnings
-$5.29
-$3.53
-$1.76
$0.00
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 10, After Hours